{"id":746596,"date":"2023-04-11T08:36:43","date_gmt":"2023-04-11T12:36:43","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\/"},"modified":"2023-04-11T08:36:43","modified_gmt":"2023-04-11T12:36:43","slug":"reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\/","title":{"rendered":"ReShape Lifesciences\u00ae Receives Notice of Allowance for U.S. Patent Related to its Obalon\u00ae Balloon System"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN CLEMENTE, Calif., April  11, 2023  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=f-JTU4b8d5QSl73te6p1vjfXK9sIbGZMYSVd5DDCT-WsdU4bBRTqjgRcaZsCARo2fEQc9SwgyUReiefDaBMZa7mk8TWX9tIaabigBQu6MGI=\" rel=\"nofollow noopener\" target=\"_blank\"><strong>ReShape Lifesciences<\/strong><\/a><strong>\u2122 (Nasdaq: RSLS), <\/strong>the premier physician-led weight loss and metabolic health solutions company, today announced that the company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for patent application 16\/792,094, entitled, \u201cSystems and Methods for Determining Failure of Intragastric Devices,\u201d related to its Obalon\u00ae Balloon System. The patent will cover additional claims for the Obalon\u00ae Balloon System and is expected to provide protection into at least January 2031, without accounting for a potential Patent Term Extension (PTE).<\/p>\n<p align=\"justify\">\u201cAllowance of this patent significantly strengthens our intellectual property portfolio around innovations for the Obalon Intragastric Balloon System,\u201d stated Paul F. Hickey, President and Chief Executive Officer of ReShape Lifesciences. \u201cSince filing our first patent application in 2011, ReShape has pioneered the field, amassing a patent family around the intragastric balloon system, supported by a variety of novel, pending and protected inventions. Going forward, we will continue to build a defensive \u2018moat\u2019 around our product portfolio and commercialization efforts, while also taking offensive action to defend our patent position, when necessary.\u201d<\/p>\n<p align=\"justify\">\n        <strong>About ReShape Lifesciences\u2122<\/strong><br \/>\n        <br \/>ReShape Lifesciences\u00ae is America\u2019s premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-Band\u00ae System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. ReShapeCare\u2122 is a virtual weight-management program that supports lifestyle changes for all weight loss patients led by board-certified health coaches to help them keep the weight off over time. The recently launched ReShape Marketplace\u2122 is an online collection of quality wellness products curated for all consumers to help them achieve their health goals. The investigational Diabetes Bloc-Stim Neuromodulation\u2122 (DBSN\u2122) system utilizes a proprietary vagus nerve block and stimulation technology platform for the treatment of Type 2 diabetes and metabolic disorders. The Obalon\u00ae balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2JuuooqpySxB0dIKOdKGIOnRCnWlPg6DkeyXUOfdvMoLM-fnAQkR6v4tK7jWyYn2jH1NmWtKPtXVAfRODQJAcT1BU50Ny0NXo-1TELaTkiWEoEFo7Yu0KJfe54w4j0kW\" rel=\"nofollow noopener\" target=\"_blank\">www.reshapelifesciences.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Forward-Looking Safe Harbor Statement <\/strong><br \/>\n        <br \/>This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from those discussed due to known and unknown risks, uncertainties, and other factors. These forward-looking statements generally can be identified by the use of words such as &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;could,&#8221; &#8220;may,&#8221; &#8220;intend,&#8221; &#8220;will,&#8221; &#8220;continue,&#8221; &#8220;future,&#8221; other words of similar meaning and the use of future dates. Forward-looking statements in this press release include statements about our future intellectual property protection measures. These and additional risks and uncertainties are described more fully in the company&#8217;s filings with the Securities and Exchange Commission, including those factors identified as &#8220;risk factors&#8221; in our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. We are providing this information as of the date of this press release and do not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise, except as required by law.<\/p>\n<p>\n        <strong>CONTACTS<\/strong><br \/>\n        <br \/>\n        <strong>ReShape Lifesciences Investor Contact:<\/strong><br \/>\n        <br \/>Thomas Stankovich<br \/>Chief Financial Officer<br \/>949-276-6042<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kByxm-bBCeoJIcnEt4uzAK9lZO_vtp5Ai5dQu_Nl_7DEnanDh0Et9NGQ42mi82iTX3045t5e8Ssf2CfTOrcQB8K4mdmopOXBj_Gr_9Vivm0N8PEr4WH0P8ujb2BBf6vzrCB6l8C8jABZaMktZZUGRUvSVUDzWUDtexIzBJMdhdPmGqtNDSyKgP183BtLXJzwQTAQ4lW5-87uKV_8RqXt43N-TupTNnR4su2egsfV4pRp3eLYcfqG-87CGvjsyhMYdn-Mtbbu5gEPgOVCw13vSg==\" rel=\"nofollow noopener\" target=\"_blank\">ir@ReShapeLifesci.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>Investor Relations Contact:<\/strong><br \/>\n        <br \/>Rx Communications Group<br \/>Michael Miller<br \/>(917)-633-6086<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nZ9XMsHg-PSjmV__EcEFxW70liZf_7xfMg4ci9cFiM2XO9b-2VxZSXjPoAqktjV2MjqRdUgSTlB6EmuH4-EMsA==\" rel=\"nofollow noopener\" target=\"_blank\">mmiller@rxir.com <\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgwNTExOSM1NTE4Nzc5IzIwMDcwNzI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/OGQyNGM1YjUtODMzOC00NGJlLTliY2UtMDE1ZjBkNDJjZjEyLTEwMTg2NDU=\/tiny\/ReShape-Lifesciences-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN CLEMENTE, Calif., April 11, 2023 (GLOBE NEWSWIRE) &#8212; ReShape Lifesciences\u2122 (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for patent application 16\/792,094, entitled, \u201cSystems and Methods for Determining Failure of Intragastric Devices,\u201d related to its Obalon\u00ae Balloon System. The patent will cover additional claims for the Obalon\u00ae Balloon System and is expected to provide protection into at least January 2031, without accounting for a potential Patent Term Extension (PTE). \u201cAllowance of this patent significantly strengthens our intellectual property portfolio around innovations for the Obalon Intragastric Balloon System,\u201d stated Paul F. Hickey, President and Chief Executive Officer &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ReShape Lifesciences\u00ae Receives Notice of Allowance for U.S. Patent Related to its Obalon\u00ae Balloon System&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-746596","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ReShape Lifesciences\u00ae Receives Notice of Allowance for U.S. Patent Related to its Obalon\u00ae Balloon System - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ReShape Lifesciences\u00ae Receives Notice of Allowance for U.S. Patent Related to its Obalon\u00ae Balloon System - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN CLEMENTE, Calif., April 11, 2023 (GLOBE NEWSWIRE) &#8212; ReShape Lifesciences\u2122 (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for patent application 16\/792,094, entitled, \u201cSystems and Methods for Determining Failure of Intragastric Devices,\u201d related to its Obalon\u00ae Balloon System. The patent will cover additional claims for the Obalon\u00ae Balloon System and is expected to provide protection into at least January 2031, without accounting for a potential Patent Term Extension (PTE). \u201cAllowance of this patent significantly strengthens our intellectual property portfolio around innovations for the Obalon Intragastric Balloon System,\u201d stated Paul F. Hickey, President and Chief Executive Officer &hellip; Continue reading &quot;ReShape Lifesciences\u00ae Receives Notice of Allowance for U.S. Patent Related to its Obalon\u00ae Balloon System&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-11T12:36:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgwNTExOSM1NTE4Nzc5IzIwMDcwNzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ReShape Lifesciences\u00ae Receives Notice of Allowance for U.S. Patent Related to its Obalon\u00ae Balloon System\",\"datePublished\":\"2023-04-11T12:36:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\\\/\"},\"wordCount\":564,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgwNTExOSM1NTE4Nzc5IzIwMDcwNzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\\\/\",\"name\":\"ReShape Lifesciences\u00ae Receives Notice of Allowance for U.S. Patent Related to its Obalon\u00ae Balloon System - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgwNTExOSM1NTE4Nzc5IzIwMDcwNzI=\",\"datePublished\":\"2023-04-11T12:36:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgwNTExOSM1NTE4Nzc5IzIwMDcwNzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgwNTExOSM1NTE4Nzc5IzIwMDcwNzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ReShape Lifesciences\u00ae Receives Notice of Allowance for U.S. Patent Related to its Obalon\u00ae Balloon System\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ReShape Lifesciences\u00ae Receives Notice of Allowance for U.S. Patent Related to its Obalon\u00ae Balloon System - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\/","og_locale":"en_US","og_type":"article","og_title":"ReShape Lifesciences\u00ae Receives Notice of Allowance for U.S. Patent Related to its Obalon\u00ae Balloon System - Market Newsdesk","og_description":"SAN CLEMENTE, Calif., April 11, 2023 (GLOBE NEWSWIRE) &#8212; ReShape Lifesciences\u2122 (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for patent application 16\/792,094, entitled, \u201cSystems and Methods for Determining Failure of Intragastric Devices,\u201d related to its Obalon\u00ae Balloon System. The patent will cover additional claims for the Obalon\u00ae Balloon System and is expected to provide protection into at least January 2031, without accounting for a potential Patent Term Extension (PTE). \u201cAllowance of this patent significantly strengthens our intellectual property portfolio around innovations for the Obalon Intragastric Balloon System,\u201d stated Paul F. Hickey, President and Chief Executive Officer &hellip; Continue reading \"ReShape Lifesciences\u00ae Receives Notice of Allowance for U.S. Patent Related to its Obalon\u00ae Balloon System\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-11T12:36:43+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgwNTExOSM1NTE4Nzc5IzIwMDcwNzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ReShape Lifesciences\u00ae Receives Notice of Allowance for U.S. Patent Related to its Obalon\u00ae Balloon System","datePublished":"2023-04-11T12:36:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\/"},"wordCount":564,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgwNTExOSM1NTE4Nzc5IzIwMDcwNzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\/","name":"ReShape Lifesciences\u00ae Receives Notice of Allowance for U.S. Patent Related to its Obalon\u00ae Balloon System - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgwNTExOSM1NTE4Nzc5IzIwMDcwNzI=","datePublished":"2023-04-11T12:36:43+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgwNTExOSM1NTE4Nzc5IzIwMDcwNzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgwNTExOSM1NTE4Nzc5IzIwMDcwNzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-receives-notice-of-allowance-for-u-s-patent-related-to-its-obalon-balloon-system\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ReShape Lifesciences\u00ae Receives Notice of Allowance for U.S. Patent Related to its Obalon\u00ae Balloon System"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/746596","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=746596"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/746596\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=746596"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=746596"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=746596"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}